These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 23542331

  • 1. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R, Zoller H, Schmidt HH, Reuner U, Hefter H, Trocello JM, Houwen RH, Ferenci P, Stremmel W, EUROWILSON Consortium.
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients.
    Lee EJ, Woo MH, Moon JS, Ko JS.
    Orphanet J Rare Dis; 2024 Jul 09; 19(1):261. PubMed ID: 38982450
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
    Santiago R, Gottrand F, Debray D, Bridoux L, Lachaux A, Morali A, Lapeyre D, Lamireau T.
    J Pediatr Gastroenterol Nutr; 2015 Dec 09; 61(6):613-8. PubMed ID: 26230903
    [Abstract] [Full Text] [Related]

  • 9. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S, Taly AB.
    J Neurol Sci; 2008 Jan 15; 264(1-2):129-32. PubMed ID: 17765927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.
    Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, Ferenci P, Stremmel W.
    Gastroenterology; 2011 Apr 15; 140(4):1189-1198.e1. PubMed ID: 21185835
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis and treatment of Wilson disease in Japan].
    Shimizu N.
    Rinsho Shinkeigaku; 2019 Sep 25; 59(9):565-569. PubMed ID: 31474637
    [Abstract] [Full Text] [Related]

  • 13. Worsening of Wilson disease following penicillamine therapy.
    Kalita J, Kumar V, Chandra S, Kumar B, Misra UK.
    Eur Neurol; 2014 Sep 25; 71(3-4):126-31. PubMed ID: 24356057
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
    Kobayashi S, Kodama H, Inuzuka R, Mori Y, Yanagawa Y.
    Pediatr Int; 2005 Oct 25; 47(5):589-91. PubMed ID: 16190972
    [No Abstract] [Full Text] [Related]

  • 16. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B, Chung SJ, Shin HW.
    J Clin Neurosci; 2013 Apr 25; 20(4):606-8. PubMed ID: 23274038
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T, Hartvig P, Löfholm M, Nordlinder H, Lööf L, Westermark K.
    QJM; 1995 Sep 25; 88(9):609-16. PubMed ID: 7583074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.